Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: J Neurochem. 2011 Jan 19;117(5):765–778. doi: 10.1111/j.1471-4159.2010.07141.x

Table 1.

LRR, Neurexins and Neuroligins implicated in human neurological diseases.

Gene Associated disease Reference
LRRTM1 Schizophrenia (Francks et al. 2007)
LRRTM3 Alzheimer’s disease (late onset) (Majercak et al. 2006)
ASD (Liang et al. 2007)
(Sousa et al. 2010)
Neurexin1 ASD (Kim et al. 2008)
(Szatmari et al. 2007)
Neuroligin1 ASD (Glessner et al. 2009)
Neuroligin3 ASD (Jamain et al. 2003)
(Talebizadeh et al. 2006)
Neuroligin4X ASD (Jamain et al. 2003)
(Pampanos et al. 2009)
(Talebizadeh et al. 2006)
Neuroligin4Y ASD (Yan et al. 2008)
LGI1 Autosomal-dominant partial epilepsy with auditory features (Kalachikov et al. 2002)
Autosomal dominant lateral temporal epilepsy (Morante-Redolat et al. 2002)
LRRN3 ASD (Sousa et al. 2010)
LRFN5 ASD (Wang et al. 2009)
LRRN1 Recessive non-syndromic mental retardation (Higgins et al. 2004)
SLITRK1 Tourette’s syndrome (Abelson et al. 2005)
SLITRK2 ASD (Piton et al. 2010)
Bipolar disorder (Smith et al. 2009)